I read the executive order last night. Seems to be a mixture of price controls and actions to create transparency and competition (increasing availability of biosimilars and generics). The price control portion will not lower prices - it will raise prices in other areas - costing the consumer more money, most likely. Price controls never work, every where they are tried. They create shortages, surpluses, or scarcity depending on the circumstances and how the market responds.
The transparency measures, I guess are ok, though I think more regulations aren’t the best way to achieve transparency in pricing. Gov intervention distorts pricing and market info.
This administration has generally been bad for pharma and health - honestly, the democrats aren’t any better they pass price controls just as frequently, with who knows what pending after RFK Jr in threatening to go after “ingredients” in drugs. More regulation and top down control on pharma industry will hurt consumers.